Recombinant luteinizing hormone in ovarian hyperstimulation after stimulation failure in normogonadotropic women
- PMID: 10399054
- DOI: 10.3109/09513599909167540
Recombinant luteinizing hormone in ovarian hyperstimulation after stimulation failure in normogonadotropic women
Abstract
The aim of this study was to examine the effect of an additional administration of recombinant luteinizing hormone (r-LH) to a gonadotropin-releasing hormone agonist (GnRHa) long protocol using recombinant follicle-stimulating hormone (r-FSH). In particular we determined whether such a stimulation protocol would be more effective in women (1) who respond poorly to stimulation with GnRHa long protocol using r-FSH only, and (2) whose LH concentrations after down-regulation in the cancelled cycle were low but above the values reported in the literature to be sufficient for folliculogenesis. After GnRHa desensitization 150 IU r-FSH and 75 IU r-LH were administered subcutaneously daily to six normogonadotropic women with low response to ovarian hyperstimulation using a GnRHa long protocol with r-FSH and low LH concentrations after down-regulation in the cancelled cycle. All six women had an oocyte retrieval and an embryo transfer after follicular stimulation. One women conceived but had a miscarriage in the eleventh week of gestation. Our results suggest that women with low response to a GnRHa long protocol with r-FSH, and whose LH concentration after down-regulation in the cancelled cycles were low, benefit from the additional administration of r-LH in a GnRHa long protocol using r-FSH. It seems that due to the additional administration of r-LH the LH concentration in the follicular phase is sufficient to support folliculogenesis.
Similar articles
-
Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.Hum Reprod. 2015 May;30(5):1188-95. doi: 10.1093/humrep/dev038. Epub 2015 Mar 3. Hum Reprod. 2015. PMID: 25740882 Clinical Trial.
-
Influence of serum follicle stimulating hormone to luteinizing hormone ratio during buserelin acetate-induced pituitary desensitization on ovarian response to exogenous gonadotrophins in an in-vitro fertilization and embryo transfer programme.Hum Reprod. 1996 Aug;11(8):1615-9. doi: 10.1093/oxfordjournals.humrep.a019456. Hum Reprod. 1996. PMID: 8921103
-
A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysis.Eur J Obstet Gynecol Reprod Biol. 2014 Jan;172:70-3. doi: 10.1016/j.ejogrb.2013.10.027. Epub 2013 Nov 5. Eur J Obstet Gynecol Reprod Biol. 2014. PMID: 24314801
-
Developments in drugs for ovarian stimulation.Best Pract Res Clin Obstet Gynaecol. 2003 Apr;17(2):231-47. doi: 10.1016/s1521-6934(02)00168-2. Best Pract Res Clin Obstet Gynaecol. 2003. PMID: 12758097 Review.
-
The role of gonadotropins in follicular development and their use in ovulation induction protocols for assisted reproduction.Eur J Contracept Reprod Health Care. 2000 Jun;5(2):157-67. doi: 10.1080/13625180008500389. Eur J Contracept Reprod Health Care. 2000. PMID: 10943580 Review.
Cited by
-
Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech.Clinics (Sao Paulo). 2014;69(4):279-93. doi: 10.6061/clinics/2014(04)10. Clinics (Sao Paulo). 2014. PMID: 24714837 Free PMC article. Review.
-
Efficacy of low dose hCG on oocyte maturity for ovarian stimulation in poor responder women undergoing intracytoplasmic sperm injection cycle: a randomized controlled trial.J Assist Reprod Genet. 2012 Nov;29(11):1213-20. doi: 10.1007/s10815-012-9854-3. Epub 2012 Sep 7. J Assist Reprod Genet. 2012. PMID: 22956348 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources